ZOVYDD
Live / Registered — Registered (as of 31 Oct 2023)
What this means for you
Registered since 31 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90534048
- Registration number
- 7204292
- Mark type
- Stylized text
- Filed
- 18 Feb 2021
- Published for opposition
- 15 Aug 2023
- Registered
- 31 Oct 2023
- Attorney of record
- Jennifer Fraser
Goods and services
- Class 001 — Chemicals: Chemicals and biological preparations being biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes; Peptide carrier molecules for association with a biological macromolecule being biological preparations for use in the pharmaceutical industry; Peptidic carrier molecule for preparing a pharmaceutical composition being biological preparations for use in the pharmaceutical industry; Peptide carrier molecule in combination with a biological macromolecule for preparing a pharmaceutical composition being biological preparations for use in the pharmaceutical industry
- Class 005 — Pharmaceuticals: Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment or prevention of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements; Vaccines; Vaccines for the prophylaxis of viral diseases
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, analysis, and testing in the field of biological molecules, in particular for identification, testing and characterisation of biological molecules; scientific and technological services, namely, scientific pre-clinical and clinical testing of macromolecules in the field of biological molecules
- Class 044 — Medical, beauty and agricultural services: Medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders
Owner
- CUREVAC SE, TÜBINGEN, DE
- CUREVAC SE, TÜBINGEN, DE
- CUREVAC SE, TÜBINGEN, DE
- CureVac AG, Tübingen, DE
Prosecution history
- 31 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 15 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Aug 2023 — PUBLISHED FOR OPPOSITION
- 26 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Jul 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jun 2023 — ASSIGNED TO EXAMINER
- 08 Jun 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Jun 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Jun 2023 — ASSIGNED TO LIE
- 08 Mar 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Feb 2023 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 11 Jan 2023 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 11 Jan 2023 — INQUIRY TO SUSPENSION E-MAILED
- 11 Jan 2023 — SUSPENSION INQUIRY WRITTEN